Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Intravitreal Rituximab
Authors not listed
Washington University School of Medicine · 2014
Abstract
The purpose of this study is to determine if treatment of Age Related Macular Degeneration (AMD) with a new medication,rituximab is effective. To address this issue, investigators propose a clinical trial in which patients with late stage disease, poor vision and who have failed treatment by conventional means will receive rituximab by direct injection into the affected eye and will be followed for improvement in the structure of their retina. Age Related Macular Degeneration (AMD) is a leading cause of vision loss in the elderly with routine care involving injections in the eye to improve and to prevent worsening of vision. However, some patients do not respond to the medications that we currently have and as such an alternative medication is needed. One potential medication is rituximab, which has been injected into the eye for primary eye cancer, and has been tolerated well and led to patient improvement. Investigators will obtain baseline eye tests then plan on injecting this medication in to the eye of our patients with late stage AMD, by first placing numbing drops into the eye, then injecting the medication directly into the eye using sterile techniques. Investigators will then follow the patient and repeat eye tests to monitor for improvements.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2014). Intravitreal Rituximab. <em>Washington University School of Medicine</em>. https://clinicaltrials.gov/study/NCT02332941
Vancouver
Anonymous. Intravitreal Rituximab. Washington University School of Medicine. 2014.
BibTeX
@misc{anon2014Intrav,
title = {Intravitreal Rituximab},
author = {Anonymous},
journal = {Washington University School of Medicine},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2008
Citation only
Age‐related Macular Degeneration (AMD)
University of Utah 2026
Open access · US-GOV
Integration of Lesion-tailored, Fundus-controlled Perimetry Into Routine Clinical Care for Patients With Geographic Atrophy (GA) Receiving Pegcetacoplan Treatment in Accordance With the Approved Label.
National Eye Institute (NEI) 2003
Open access · US-GOV
Pilot Study of Intravitreal Injection of EYE001 (Anti-VEGF Pegylated Aptamer) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease
National Eye Institute (NEI) 2001
Open access · US-GOV
A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 2025
Open access · US-GOV
Impact of a Program Aimed at Improving Frailty in Patients With Stable Ischemic Heart Disease in Primary Care: Fragicor Study
Novartis Pharmaceuticals 2014
Open access · US-GOV